These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27755184)

  • 1. No! When the immunologist becomes a virologist: Norovirus - an emerging infection in immune deficiency diseases.
    Hartono S; Bhagia A; Joshi AY
    Curr Opin Allergy Clin Immunol; 2016 Dec; 16(6):557-564. PubMed ID: 27755184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic norovirus infection in primary immune deficiency disorders: an international case series.
    Rolfes MC; Sriaroon P; Dávila Saldaña BJ; Dvorak CC; Chapdelaine H; Ferdman RM; Chen K; Jolles S; Patel NC; Kim YJ; Tarrant TK; Martelius T; Seppanen M; Joshi AY
    Diagn Microbiol Infect Dis; 2019 Jan; 93(1):69-73. PubMed ID: 30174143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norovirus Regulation by Host and Microbe.
    Baldridge MT; Turula H; Wobus CE
    Trends Mol Med; 2016 Dec; 22(12):1047-1059. PubMed ID: 27887808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norovirus.
    Robilotti E; Deresinski S; Pinsky BA
    Clin Microbiol Rev; 2015 Jan; 28(1):134-64. PubMed ID: 25567225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norovirus Infection: Replication, Manipulation of Host, and Interaction with the Host Immune Response.
    Sarvestani ST; Cotton B; Fritzlar S; O'Donnell TB; Mackenzie JM
    J Interferon Cytokine Res; 2016 Apr; 36(4):215-25. PubMed ID: 27046239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norovirus mechanisms of immune antagonism.
    Roth AN; Karst SM
    Curr Opin Virol; 2016 Feb; 16():24-30. PubMed ID: 26673810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral shape-shifting: norovirus evasion of the human immune system.
    Donaldson EF; Lindesmith LC; Lobue AD; Baric RS
    Nat Rev Microbiol; 2010 Mar; 8(3):231-41. PubMed ID: 20125087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norovirus infection in immunocompromised hosts.
    Green KY
    Clin Microbiol Infect; 2014 Aug; 20(8):717-23. PubMed ID: 25040790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noroviruses: epidemiology, immunity and prospects for prevention.
    Pringle K; Lopman B; Vega E; Vinje J; Parashar UD; Hall AJ
    Future Microbiol; 2015; 10(1):53-67. PubMed ID: 25598337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates of Protection against Norovirus Infection and Disease-Where Are We Now, Where Do We Go?
    Ramani S; Estes MK; Atmar RL
    PLoS Pathog; 2016 Apr; 12(4):e1005334. PubMed ID: 27115358
    [No Abstract]   [Full Text] [Related]  

  • 11. Differentiation and Protective Capacity of Virus-Specific CD8
    Tomov VT; Palko O; Lau CW; Pattekar A; Sun Y; Tacheva R; Bengsch B; Manne S; Cosma GL; Eisenlohr LC; Nice TJ; Virgin HW; Wherry EJ
    Immunity; 2017 Oct; 47(4):723-738.e5. PubMed ID: 29031786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norovirus immunology: Of mice and mechanisms.
    Newman KL; Leon JS
    Eur J Immunol; 2015 Oct; 45(10):2742-57. PubMed ID: 26256101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Norovirus gastroenteritis: frequent, often epidemic, with potentially severe complications].
    Kundig F; Chevalley P; Genné D
    Rev Med Suisse; 2013 Oct; 9(401):1806-8, 1810-1. PubMed ID: 24191413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal administration of a recombinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice.
    Guo L; Wang J; Zhou H; Si H; Wang M; Song J; Han B; Shu Y; Ren L; Qu J; Hung T
    Vaccine; 2008 Jan; 26(4):460-8. PubMed ID: 18160189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of immune deficiency increases the risk of hospitalization in patients with norovirus infection.
    Sacco KA; Pongdee T; Binnicker MJ; Espy M; Pardi D; Khanna S; Joshi AY
    Diagn Microbiol Infect Dis; 2018 Apr; 90(4):300-306. PubMed ID: 29398461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norovirus encounters in the gut: multifaceted interactions and disease outcomes.
    Hassan E; Baldridge MT
    Mucosal Immunol; 2019 Nov; 12(6):1259-1267. PubMed ID: 31501514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profound diarrhoea and weight loss in an immunocompromised patient.
    Ashton G; Shand A; Arnott I; Din S
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33462001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations.
    Donaldson EF; Lindesmith LC; Lobue AD; Baric RS
    Immunol Rev; 2008 Oct; 225():190-211. PubMed ID: 18837783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress toward norovirus vaccines: considerations for further development and implementation in potential target populations.
    Aliabadi N; Lopman BA; Parashar UD; Hall AJ
    Expert Rev Vaccines; 2015; 14(9):1241-53. PubMed ID: 26224658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in understanding of the innate immune response to human norovirus infection using organoid models.
    Mboko WP; Chhabra P; Valcarce MD; Costantini V; Vinjé J
    J Gen Virol; 2022 Jan; 103(1):. PubMed ID: 35077345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.